Abstract:

[Abstract] In recent years, peritoneal dialysis (PD) has become one of the most important replacement therapy in patients with the end-stage renal disease (ESRD), because of its unique protection of residual renal function (RRF). However, because of the biological incompatibility of peritoneal dialysis fluid, the development of peritoneal dialysis restricted by peritoneal fibrosis in peritoneal dialysis. The effective therapeutic methods of peritoneal fibrosis related with peritoneal dialysis are still in exploration.

Key words: Peritoneal dialysis, Peritoneal fibrosis, Therapeutic measures